358 related articles for article (PubMed ID: 27562241)
21. Increased hospital length of stay attributable to Clostridium difficile infection in patients with four co-morbidities: an analysis of hospital episode statistics in four European countries.
Eckmann C; Wasserman M; Latif F; Roberts G; Beriot-Mathiot A
Eur J Health Econ; 2013 Oct; 14(5):835-46. PubMed ID: 23797490
[TBL] [Abstract][Full Text] [Related]
22. Attributable costs and length of stay of hospital-acquired
Leal JR; Conly J; Weaver R; Wick J; Henderson EA; Manns B; Ronksley P
Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1135-1143. PubMed ID: 31342884
[TBL] [Abstract][Full Text] [Related]
23. Burden of Clostridium difficile on the healthcare system.
Dubberke ER; Olsen MA
Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S88-92. PubMed ID: 22752870
[TBL] [Abstract][Full Text] [Related]
24. A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissions.
Nanwa N; Sander B; Krahn M; Daneman N; Lu H; Austin PC; Govindarajan A; Rosella LC; Cadarette SM; Kwong JC
PLoS One; 2017; 12(3):e0172410. PubMed ID: 28257438
[TBL] [Abstract][Full Text] [Related]
25. Is it financially beneficial for hospitals to prevent nosocomial infections?
Benenson S; Cohen MJ; Schwartz C; Revva M; Moses AE; Levin PD
BMC Health Serv Res; 2020 Jul; 20(1):653. PubMed ID: 32664922
[TBL] [Abstract][Full Text] [Related]
26. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study.
Tabak YP; Zilberberg MD; Johannes RS; Sun X; McDonald LC
Infect Control Hosp Epidemiol; 2013 Jun; 34(6):588-96. PubMed ID: 23651889
[TBL] [Abstract][Full Text] [Related]
27. Hospital-acquired Clostridium difficile infection: an institutional costing analysis.
Choi KB; Suh KN; Muldoon KA; Roth VR; Forster AJ
J Hosp Infect; 2019 Jun; 102(2):141-147. PubMed ID: 30690051
[TBL] [Abstract][Full Text] [Related]
28. Consequences of Clostridium difficile infection: understanding the healthcare burden.
Bouza E
Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():5-12. PubMed ID: 23121549
[TBL] [Abstract][Full Text] [Related]
29. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection.
Wiegand PN; Nathwani D; Wilcox MH; Stephens J; Shelbaya A; Haider S
J Hosp Infect; 2012 May; 81(1):1-14. PubMed ID: 22498638
[TBL] [Abstract][Full Text] [Related]
30. The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases.
Olsen MA; Young-Xu Y; Stwalley D; Kelly CP; Gerding DN; Saeed MJ; Mahé C; Dubberke ER
BMC Infect Dis; 2016 Apr; 16():177. PubMed ID: 27102582
[TBL] [Abstract][Full Text] [Related]
31. Economic Burden of Clostridium difficile Infection in European Countries.
Reigadas Ramírez E; Bouza ES
Adv Exp Med Biol; 2018; 1050():1-12. PubMed ID: 29383660
[TBL] [Abstract][Full Text] [Related]
32. Healthcare resource use and attributable cost of Clostridium difficile infection: a micro-costing analysis comparing first and recurrent episodes.
Tresman R; Goldenberg SD
J Antimicrob Chemother; 2018 Oct; 73(10):2851-2855. PubMed ID: 29982502
[TBL] [Abstract][Full Text] [Related]
33. Economic burden and cost-effective management of Clostridium difficile infections.
Heimann SM; Cruz Aguilar MR; Mellinghof S; Vehreschild MJGT
Med Mal Infect; 2018 Feb; 48(1):23-29. PubMed ID: 29336929
[TBL] [Abstract][Full Text] [Related]
34. Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection.
Miller AC; Polgreen LA; Cavanaugh JE; Polgreen PM
Infect Control Hosp Epidemiol; 2016 Apr; 37(4):404-10. PubMed ID: 26858126
[TBL] [Abstract][Full Text] [Related]
35. Incidence and Costs of Clostridium difficile Infections in Canada.
Levy AR; Szabo SM; Lozano-Ortega G; Lloyd-Smith E; Leung V; Lawrence R; Romney MG
Open Forum Infect Dis; 2015 Sep; 2(3):ofv076. PubMed ID: 26191534
[TBL] [Abstract][Full Text] [Related]
36. Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009-2011.
Magee G; Strauss ME; Thomas SM; Brown H; Baumer D; Broderick KC
Am J Infect Control; 2015 Nov; 43(11):1148-53. PubMed ID: 26521932
[TBL] [Abstract][Full Text] [Related]
37. Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).
Wingen-Heimann SM; Davies K; Viprey VF; Davis G; Wilcox MH; Vehreschild MJGT; Lurienne L; Bandinelli PA; Cornely OA; Vilken T; Hopff SM; Vehreschild JJ;
Clin Microbiol Infect; 2023 May; 29(5):651.e1-651.e8. PubMed ID: 36586512
[TBL] [Abstract][Full Text] [Related]
38. Assessing the burden of Clostridium difficile infections for hospitals.
Hebbinckuys E; Marissal JP; Preda C; Leclercq V
J Hosp Infect; 2018 Jan; 98(1):29-35. PubMed ID: 28890287
[TBL] [Abstract][Full Text] [Related]
39. Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life.
Wilcox MH; Ahir H; Coia JE; Dodgson A; Hopkins S; Llewelyn MJ; Settle C; Mclain-Smith S; Marcella SW
J Antimicrob Chemother; 2017 Sep; 72(9):2647-2656. PubMed ID: 28633368
[TBL] [Abstract][Full Text] [Related]
40. The economic impact of Clostridium difficile infection: a systematic review.
Nanwa N; Kendzerska T; Krahn M; Kwong JC; Daneman N; Witteman W; Mittmann N; Cadarette SM; Rosella L; Sander B
Am J Gastroenterol; 2015 Apr; 110(4):511-9. PubMed ID: 25848925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
